Quantification of Aβ plaques in the brains of the AD-tau-injected 5XFAD mice (see example in Additional file 1: Fig. S4A) revealed a significant decrease in cortical Aβ plaque signal in the mice treated with PLX3397 (Fig. 3a, c). Here, MAPT is linked to Alzheimer disease.